Background: Extended Spectrum β -Lactameses Producing Organisms (ESBLs) are increasing in number and causing more severe infections because of their continuous mutation and multidrug resistance property with limited therapeutic option. Aims and Objectives: Present study was undertaken to detect the prevalence of the ESBLs producing bacteria in wound infection, so as to provide a base line data in treating them & prevent unnecessary use of antibiotics Methods: Isolated gram-negative bacteria initially screened by Minimum Inhibitory Concentration (MIC) ESBLs breakpoints. Then suspected ESBLs producers were confirmed by Phenotypic confirmatory test. Results: 105 (One hundred five) (91.30%) bacterial strains were isolated from 115 samples of wound swab & pus from different patients were studied of which 84(80.00%) were Gram-negative and 21(20.00%) were Gram-positive. Among the isolated Gram-negative bacteria 79(94.05%) were found suspected ESBLs producers of which 54(68.35%) were found as confirmed ESBL producers. The prevalence of ESBLs producing organisms in the present study were found to be 64.29% and Klebsiella spp as most prevalent ESBLs producers. Conclusion: It is essential to report ESBL production along with routine sensitivity reporting, which will help the clinician in prescribing the proper antibiotics.
INTRODUCTION
Antimicrobial resistance is emerging as one of the major public health threats at the beginning of the 21 st century worldwide including Bangladesh. The wide spread use and in some cases, misuse of antimicrobials in all health care settings over the past several decades has been cited as a contributing factor in the development of drug resistance in virtually all bacterial species. The accelerated emergence of antibiotic resistance among the prevalent pathogens is the most serious threat to the management of infectious diseases 1 . Infections by extended spectrum beta lactamases (ESBLs) producing organisms are causing significant diagnostic and therapeutic problems in affected patient's 2 . ESBLs are mutant forms of β-lactamases enzymes coded by genes located on transferable plasmids, which can easily spread form one organism to another. The ESBL producing organisms are often multi drug resistant, as the plasmids producing ESBLs can carry resistance to other antibiotics 3 . Extended spectrum β-lactamases producing bacteria produce Extended Spectrum β-Lactamases (ESBLs) enzymes that mediate resistance to extended spectrum (Third generation) cephalosporins and monobactams but do not affect cephamycins (e.g. Cefoxitin and cefotatan) or carbapenems and are inhibited by β-lactamase inhibitors such as clavulanate, sulbactam and tazobactam 1, 4, 5 . The ESBL producing bacteria are increasingly becoming a major threat for patients in the hospital, long term care facilities and community. The increasing drug resistance among these bacteria has made therapy difficult and has led to a greater use of expensive broad spectrum antibiotics 6 . Inappropriate antibiotic selection in infections caused by these organisms is associated with treatment failures, poor clinical outcomes, prolonged hospital stay, increased morbidity, mortality and health care costs. The widespread use of the third generation cephalosporins and aztreonam is believed to be the major cause of the mutations in these enzymes 7. Drug resistance of this form is often difficult to recognize using conventional antimicrobial susceptibility methods. Failure to identify ESBL producing organisms also contributes to their uncontrolled spread. Therefore, identification of the resistant phenotypes is important, particularly in developing countries where there is excessive use of antibiotics and lack of adequate antimicrobial resistance surveillance 8, 9 . This study was designed to investigate the prevalence of ESBLs producing organisms among wound infections which would guide clinicians and microbiologists for proper handling of these pathogens & prevent unnecessary use of antibiotics. A sterile technique was applied to aspirate or collect pus or wound swab from abscess or wound infection, either by disposable syringe or by sterile swab stick and inoculated in Blood agar and Mac Conkey agar media. After overnight incubation at 37°C, plates were checked for presence of any suspected pathogens. Identification of organisms were done as per standard laboratory methods of identification and antimicrobial sensitivity of the isolates were tested against different antibiotics.
MATERIALS AND METHODS

ESBL detection:
The method recommended by Clinical Laboratories Standard Institute (CLSI) requires a two step approach of initially screening for ESBL production and then performing confirmatory tests on screen positive isolates 10 . 
Screening for ESBL producers by dilution method
DISCUSSION
In the present study, 105(91.30%) bacteria were isolated from 115 wound swab & pus samples from different patients (Figure 1 ). This result is closely related to that of Rahman in Bangabandhu Sheikh Mujib Medical University(BSMMU) Dhaka, who found 93.92% bacterial isolates from wound swab & pus samples 11 . Among the bacterial isolates, 84(80.00%) were gram-negative and 21(20.00%) were gram-positive in our study (Table 1) . Similar to present study, Rahman found 90% gram-negative & 10% gram-positive isolates 11 . Amongst the isolates, Klebsiella spp (24.76%) was the predominant organism, followed by E. Coli (23.81%) Pseudomonas spp (21.90%) Staphylococcus aureus (17.14%) Proteus spp (9.53%) and Coagulase-negative staphylococci (2.86%). Sule et al. in Nigeria also found Klebsiella spp (25.3%) as the most common bacterial isolates from wound swab 12 . In contrast to present study Rahman et al. of Dhaka, found Staphylococcus aureus (39.44%) was the principal organism, followed by Klebsiella spp (21.13%) E. Coli (11.27%) Proteus spp (08.45%) and Pseudomonas spp (05.63%) in surgical wound 13 . These different findings may be due to that etiological agents may however, vary from country to country, from hospital to hospital and from one community to another 14 . As of now, no country wide study has been conducted for the detection of the prevalence of ESBL production in Bangladesh, individual studies which were done in different parts of the country showed a varying prevalence, based on various risk factors and local reasons. In the present study, we found 79(94.05%) suspected ESBLs producers from 84 gram-negative isolates, based on Minimum Inhibitory Concentration (MIC) ESBLs screening breakpoints ( Figure 2 ). As using more than one antibiotic increase the sensitivity, we used three third generation cephalosporins (Ceftriaxone, ceftazidime & cefotaxime) for the screening 10 .
Our finding is closely related to that of Metri et al. in North Karnataka, India, who found 91.74% suspected ESBLs producers by screening test 7 . When these 79 screening positive isolates were subjected to the confirmatory tests, 54(68.35%) were confirmed as ESBL producers by phenotypic confirmatory test (Figure 3 ).
The prevalence of ESBLs producing organisms in the present study were found (Table II) The variation on ESBL positivity might be due to the number of isolates studied, variation in institution to institution & geographic location 5, 8 . The prevalence of ESBL production is high in the referral centers and the intensive care unites where the patients are referred from the peripheral centers and where the antibiotic use is profuse 7 . The uncontrolled use of 3rd generation cephalosporins at the hospital could be a leading contributory factor to the high ESBLs prevalence 19 .
ESBLs are most commonly recognized in Klebsiella spp and E. Coli and most prevalent in Klebsiella pneumoniae 20, 21 . We also found Klebsiella spp (73.03%) as the leading ESBLs producers followed by E. Coli (68.00%) Pseudomonas spp (50.00%) and Proteus spp (50.00%) in our study, which correlates with those of Rahman & Alim both in BSMMU, Yasmin of Mymensingh who also found Klebsiella spp as the most common ESBL producers 11, 15, 17 . The high occurrence of ESBLs in Klebsiella spp is of great concern since infections caused by this bacterium are very common and resistance of the organism may be due to the presence of capsule & multidrug resistance efflux pump, easy spreading nature, pathogenic and efficient at acquiring and disseminating resistance plasmid and production of endotoxin, carbapenemases, which make it more resistant 22 .
CONCLUSION
Existing of extended spectrum β-lactameses in bacteria and their potential multidrug resistance will create serious problem in the future as their continuous mutation and limited therapeutic option. Indiscriminate use of antibiotics especially 3rd generation cephalosporins and monobactams should be avoided. The regular detection of ESBLs producing organisms should be carried out in every laboratory.
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